Johnson Non Operating Income Net Other from 2010 to 2025

JNJ Stock  USD 156.15  0.00  0.00%   
Johnson Johnson Non Operating Income Net Other yearly trend continues to be relatively stable with very little volatility. Non Operating Income Net Other may rise above about -1.2 B this year. During the period from 2010 to 2025, Johnson Johnson Non Operating Income Net Other yarly data series regression line had median of (1,180,755,000) and sample variance of 1775371.4 T. View All Fundamentals
 
Non Operating Income Net Other  
First Reported
2009-06-30
Previous Quarter
-953 M
Current Value
-7 B
Quarterly Volatility
1.4 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Johnson Johnson financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Johnson Johnson's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9 B, Interest Expense of 792.8 M or Total Revenue of 49.8 B, as well as many indicators such as Price To Sales Ratio of 2.87, Dividend Yield of 0.0179 or PTB Ratio of 4.94. Johnson financial statements analysis is a perfect complement when working with Johnson Johnson Valuation or Volatility modules.
  
Check out the analysis of Johnson Johnson Correlation against competitors.
For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.

Latest Johnson Johnson's Non Operating Income Net Other Growth Pattern

Below is the plot of the Non Operating Income Net Other of Johnson Johnson over the last few years. It is Johnson Johnson's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Johnson Johnson's overall financial position and show how it may be relating to other accounts over time.
Non Operating Income Net Other10 Years Trend
Pretty Stable
   Non Operating Income Net Other   
       Timeline  

Johnson Non Operating Income Net Other Regression Statistics

Arithmetic Mean(936,165,938)
Geometric Mean918,118,621
Coefficient Of Variation(142.33)
Mean Deviation1,044,270,195
Median(1,180,755,000)
Standard Deviation1,332,430,641
Sample Variance1775371.4T
Range5B
R-Value(0.18)
Mean Square Error1843880.6T
R-Squared0.03
Significance0.52
Slope(48,997,096)
Total Sum of Squares26630571.2T

Johnson Non Operating Income Net Other History

2025-1.2 B
2024-1.2 B
2022-1.4 B
2021-436 M
2020-2.8 B
2019-2.2 B
2018-794 M

About Johnson Johnson Financial Statements

Investors use fundamental indicators, such as Johnson Johnson's Non Operating Income Net Other, to determine how well the company is positioned to perform in the future. Although Johnson Johnson's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Non Operating Income Net Other-1.2 B-1.2 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Dividend Share
4.91
Earnings Share
5.79
Revenue Per Share
36.897
Quarterly Revenue Growth
0.053
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.